Author Correction: A multicenter study of asymmetric and symmetric dimethylarginine as predictors of mortality risk in hospitalized COVID-19 patients

Juliane Hannemann¹, Anne Zink¹, Yoana Mileva¹, Paul Balfanz^{2

3}, Edgar Dahl⁴, Sonja Volland⁵, Thomas Illig⁵, Edzard Schwedhelm^{1

6}, Florian Kurth⁷, Alexandra Stege⁸, Martin Aepfelbacher⁹, Armin Hofmann⁹, Rainer Böger^{10

11}

Affiliations

¹ Institute of Clinical Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
² Department of Cardiology, Angiology and Intensive Care Medicine, Medical Clinic I, University Hospital Aachen, Aachen, Germany.
³ Department of Physiology, Henri Mondor Hospital, FHU-SENEC, INSERM U955, Université Paris-Est Créteil (UPEC), AP-HP, Créteil, France.
⁴ Institute of Pathology and Central Biobank, University Hospital Aachen, Aachen, Germany.
⁵ Hannover Unifed Biobank, Medizinische Hochschule Hannover, Hannover, Germany.
⁶ German Centre for Cardiovascular Research (DZHK), Partner Site Hamburg/Kiel/Lübeck, Hamburg, Germany.
⁷ Department of Infectious Diseases and Critical Care Medicine, Charité Universitätsmedizin Berlin, Berlin, Germany.
⁸ Central Biobank Charité, Charité Universitätsmedizin Berlin, Berlin, Germany.
⁹ Institute of Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
¹⁰ Institute of Clinical Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. boeger@uke.de.
¹¹ German Centre for Cardiovascular Research (DZHK), Partner Site Hamburg/Kiel/Lübeck, Hamburg, Germany. boeger@uke.de.

Published Erratum

Juliane Hannemann et al. Sci Rep. 2025.

. 2025 Apr 29;15(1):15048.

doi: 10.1038/s41598-025-99224-0.

¹ Institute of Clinical Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
² Department of Cardiology, Angiology and Intensive Care Medicine, Medical Clinic I, University Hospital Aachen, Aachen, Germany.
³ Department of Physiology, Henri Mondor Hospital, FHU-SENEC, INSERM U955, Université Paris-Est Créteil (UPEC), AP-HP, Créteil, France.
⁴ Institute of Pathology and Central Biobank, University Hospital Aachen, Aachen, Germany.
⁵ Hannover Unifed Biobank, Medizinische Hochschule Hannover, Hannover, Germany.
⁶ German Centre for Cardiovascular Research (DZHK), Partner Site Hamburg/Kiel/Lübeck, Hamburg, Germany.
⁷ Department of Infectious Diseases and Critical Care Medicine, Charité Universitätsmedizin Berlin, Berlin, Germany.
⁸ Central Biobank Charité, Charité Universitätsmedizin Berlin, Berlin, Germany.
⁹ Institute of Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
¹⁰ Institute of Clinical Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. boeger@uke.de.
¹¹ German Centre for Cardiovascular Research (DZHK), Partner Site Hamburg/Kiel/Lübeck, Hamburg, Germany. boeger@uke.de.

No abstract available

Erratum for

A multicenter study of asymmetric and symmetric dimethylarginine as predictors of mortality risk in hospitalized COVID-19 patients.
Hannemann J, Zink A, Mileva Y, Balfanz P, Dahl E, Volland S, Illig T, Schwedhelm E, Kurth F, Stege A, Aepfelbacher M, Hoffmann A, Böger R. Hannemann J, et al. Sci Rep. 2024 Jul 8;14(1):15739. doi: 10.1038/s41598-024-66288-3. Sci Rep. 2024. PMID: 38977837 Free PMC article.